quinazolines has been researched along with Pneumonia, Bacterial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corriden, R; Griffin, JH; Gupta, N; Liu, R; Nizet, V; Pogliano, J; Pogliano, K; Shin, S; Sinha, R | 1 |
| Carroll, J; Coffey, A; Dohnal, J; Finster, J; Jampilek, J; Kralova, K; Musiol, R; O'Mahony, J; Pesko, M; Polanski, J; Vejsova, M | 1 |
2 other study(ies) available for quinazolines and Pneumonia, Bacterial
| Article | Year |
|---|---|
SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.
Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Lung; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia, Bacterial; Pyrroles; Quinazolines; Reactive Oxygen Species; Receptor, PAR-1 | 2018 |
Investigating biological activity spectrum for novel styrylquinazoline analogues.
Topics: Antitubercular Agents; Chloroplasts; Electron Transport; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Photosynthesis; Pneumonia, Bacterial; Quinazolines; Spinacia oleracea; Styrenes | 2009 |